Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: An electronic device receives a web page having multiple media elements. Respective priorities are assigned to the multiple media elements. The media decoding resources are allocated to the media elements according to the assigned priorities.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: A method for monitoring use of a mobile hotspot function in a wireless device, comprising: storing a last access time for a client within a memory of the wireless device, the last access time being a time when the hotspot function last performed a network address translation for the client; determining whether a difference between a current time and the last access time exceeds a threshold; and, if the difference exceeds the threshold, generating an indication that the mobile hotspot function is not in use by the client.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: Techniques for use in controlling data traffic in a wireless local area network (WLAN) which includes at least one access point (AP) are described. In one illustrative example, the terminal is associated with the AP and receives data traffic from a source device via the AP. The terminal identifies whether a processing requirement of the terminal for processing data traffic exceeds a predetermined threshold. In response to such identifying, the terminal produces a control message which includes a source address corresponding to the source device and a destination address corresponding to the terminal, and sends the control message to the AP. The control message is defined to instruct the AP to prohibit transmission of the data traffic originating from the source address and destined to the destination address.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-isothiazole compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: A method and portable electronic device for presenting text portable is provided. In accordance with one example embodiment, there is provided a method to enlarge text on a portable electronic device comprising: determining a location of an onscreen position indicator in text displayed on a display screen of the portable electronic device; and displaying a selected portion of the text in an area in relation to the location of the onscreen position indicator in enlarged text.

Abstract: A fastening device comprising a pin affixed to a first zipper track, the pin comprising a first magnet and at least a first engaging element; a box affixed to a second zipper track, the box comprising a second magnet and comprising at least a second engaging element complementary to the first engaging element of the pin, wherein the pin and box form a single element through the releasable interaction of the first and second magnets, and the first engaging element of the pin reversibly interacting with the second engaging element of the box; and a first slider body, wherein the first slider body comprises at least one releasing element that reversibly disengages the first engaging element of the pin from the second engaging element of the box.

Abstract: An exhaust system for use with a diesel engine includes a diesel particulate filter configured to capture particulate matter exhausted from the diesel engine, a first sensor operable to detect a particulate matter accumulation level within the diesel particulate filter, and a second sensor operable to detect an ambient temperature of an environment surrounding the diesel particulate filter. The exhaust system also includes a control module electrically coupled to the first sensor, the second sensor, and the diesel particulate filter. The control module is operable to adjust a first regeneration threshold based on the detected ambient temperature. The control module is also operable to initiate regeneration of the diesel particulate filter when the detected particulate matter accumulation level reaches the first regeneration threshold.

Abstract: A patient support device for a radiation therapy treatment system and a method of manufacturing the same. The device includes a support having an upper surface and a lower surface and a fixture hole configuration that receives a patient fixation device. The fixture hole configuration includes at least one recess and reinforcing material positioned inside at least a portion of the at least one recess. The device may also include a lower support having an upper surface that includes at least one channel. Flat flex cable used to operate the patient support device is positioned within the at least one channel.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: A fastening device comprising a pin affixed to a first zipper track, the pin comprising a first magnet and at least a first engaging element; a box affixed to a second zipper track, the box comprising a second magnet and comprising at least a second engaging element complementary to the first engaging element of the pin, wherein the pin and box form a single element through the releasable interaction of the first and second magnets, and the first engaging element of the pin reversibly interacting with the second engaging element of the box; and a first slider body, wherein the first slider body comprises at least one releasing element that reversibly disengages the first engaging element of the pin from the second engaging element of the box.

Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11?-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11?-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.

Abstract: An exhaust system for use with a diesel engine includes a diesel particulate filter configured to capture particulate matter exhausted from the diesel engine, a first sensor operable to detect a particulate matter accumulation level within the diesel particulate filter, and a second sensor operable to detect an ambient temperature of an environment surrounding the diesel particulate filter. The exhaust system also includes a control module electrically coupled to the first sensor, the second sensor, and the diesel particulate filter. The control module is operable to adjust a first regeneration threshold based on the detected ambient temperature. The control module is also operable to initiate regeneration of the diesel particulate filter when the detected particulate matter accumulation level reaches the first regeneration threshold.

Abstract: Disclosed is a pouring dispenser for pouring liquid from a bottle, the pouring dispenser incorporating a removable nozzle section.

Abstract: A patient support device for use in a medical facility. The patient support device includes a base and a table assembly coupled to the base. The table assembly includes a lower support and an upper support coupled thereto and movable with respect to the lower support. At least one of the upper support and the lower support includes a bearing layer thereon capable of improving the performance of the patient support device when the upper support moves with respect to the lower support.

Abstract: A process comprising: submerging a fuel cell bipolar plate in a bath comprising nanoparticles and a liquid phase comprising a nanoparticles dispersion agent and wherein the bipolar plate includes an upper surface having a plurality of lands and channels formed therein; removing the fuel cell bipolar plate from the bath so that a coating comprising nanoparticles adheres to the fuel cell bipolar plate; while the coating is wet and before the coating is dried and solidified, removing the coating comprising nanoparticles from the lands of the bipolar plate, leaving coating comprising nanoparticle in the channels; and drying the coating in the channels.

Abstract: A process including coating a fuel cell component using a coating solution including nanoparticles.